0

Rhythm Disorders and Devices Collection
 21-40 of 619 Articles
Editorials |  1 November 2011
Selecting the Optimal Stroke Prevention Therapy in Atrial Fibrillation
Margaret C. Fang, MD, MPH
Ann Intern Med. 2011;155(9):636-637. doi:10.7326/0003-4819-155-9-201111010-00014
Original Research |  1 November 2011
Safety of Screening Procedures With Hand-Held Metal Detectors Among Patients With Implanted Cardiac Rhythm Devices: A Cross-sectional Analysis
Clemens Jilek, MD; Stylianos Tzeis, MD, PhD; Hrvoje Vrazic, MD, PhD; et al.
Ann Intern Med. 2011;155(9):587-592. doi:10.7326/0003-4819-155-9-201111010-00005
Original Research |  1 November 2011
Net Clinical Benefit of Adding Clopidogrel to Aspirin Therapy in Patients With Atrial Fibrillation for Whom Vitamin K Antagonists Are Unsuitable
Stuart J. Connolly, MD; John W. Eikelboom, MBBS; Jennifer Ng, MSc; et al.
Ann Intern Med. 2011;155(9):579-586. doi:10.7326/0003-4819-155-9-201111010-00004
Editorials |  4 October 2011
Magnetic Resonance Imaging and Cardiac Devices: How Safe Is Safe Enough?
Matthew R. Reynolds, MD, MSc; Peter Zimetbaum, MD
Ann Intern Med. 2011;155(7):470-472. doi:10.7326/0003-4819-155-7-201110040-00010
Original Research |  4 October 2011
A Prospective Evaluation of a Protocol for Magnetic Resonance Imaging of Patients With Implanted Cardiac Devices
Saman Nazarian, MD; Rozann Hansford, RN, MPH; Ariel Roguin, MD, PhD; et al.
Ann Intern Med. 2011;155(7):415-424. doi:10.7326/0003-4819-155-7-201110040-00004
Original Research |  4 January 2011 FREE
Cost-Effectiveness of Dabigatran Compared With Warfarin for Stroke Prevention in Atrial Fibrillation
James V. Freeman, MD, MPH; Ruo P. Zhu, BA; Douglas K. Owens, MD, MSc; et al.
Ann Intern Med. 2011;154(1):1-11. doi:10.7326/0003-4819-154-1-201101040-00289
Original Research |  7 December 2010 FREE
Metoprolol Versus Amiodarone in the Prevention of Atrial Fibrillation After Cardiac Surgery: A Randomized Trial
Jari Halonen, MD; Pertti Loponen, MD; Otso Järvinen, MD, PhD; et al.
Ann Intern Med. 2010;153(11):703-709. doi:10.7326/0003-4819-153-11-201012070-00003
Reviews |  2 November 2010
Meta-analysis: Age and Effectiveness of Prophylactic Implantable Cardioverter-Defibrillators
Pasquale Santangeli, MD; Luigi Di Biase, MD; Antonio Dello Russo, MD; et al.
Ann Intern Med. 2010;153(9):592-599. doi:10.7326/0003-4819-153-9-201011020-00009
Editorials |  17 August 2010 FREE
Toward More Uniform Conflict Disclosures: The Updated ICMJE Conflict of Interest Reporting Form
Jeffrey M. Drazen, MD; Peter W. de Leeuw, MD, PhD; Christine Laine, MD, MPH, Editor; et al.
Ann Intern Med. 2010;153(4):268-269. doi:10.7326/0003-4819-153-4-201008170-00261
Articles |  6 July 2010 FREE
Small Area Variations in Out-of-Hospital Cardiac Arrest: Does the Neighborhood Matter?
Comilla Sasson, MD, MS; Carla C. Keirns, MD, PhD, MS; Dylan Smith, PhD; et al.
Ann Intern Med. 2010;153(1):19-22. doi:10.7326/0003-4819-153-1-201007060-00255
Articles |  2 March 2010 FREE
Brief Communication: Management of Implantable Cardioverter-Defibrillators in Hospice: A Nationwide Survey
Nathan Goldstein, MD; Melissa Carlson, MBA, PhD; Elayne Livote, MPH, MS, MA; et al.
Ann Intern Med. 2010;152(5):296-299. doi:10.7326/0003-4819-152-5-201003020-00007
Articles |  2 March 2010
Cost-Effectiveness of Preparticipation Screening for Prevention of Sudden Cardiac Death in Young Athletes
Matthew T. Wheeler, MD, PhD; Paul A. Heidenreich, MD, MS; Victor F. Froelicher, MD; et al.
Ann Intern Med. 2010;152(5):276-286. doi:10.7326/0003-4819-152-5-201003020-00005
Articles |  19 January 2010
Risk for Incident Atrial Fibrillation in Patients Who Receive Antihypertensive Drugs: A Nested Case–Control Study
Beat A. Schaer, MD; Cornelia Schneider, MSc; Susan S. Jick, DSc; et al.
Ann Intern Med. 2010;152(2):78-84. doi:10.7326/0003-4819-152-2-201001190-00005
Editorials |  1 September 2009
Do Current Guidelines Result in Overuse of Warfarin Anticoagulation in Patients With Atrial Fibrillation?
Robert G. Hart, MD; Jonathan L. Halperin, MD
Ann Intern Med. 2009;151(5):355-356. doi:10.7326/0003-4819-151-5-200909010-00012
Articles |  1 September 2009
The Net Clinical Benefit of Warfarin Anticoagulation in Atrial Fibrillation
Daniel E. Singer, MD; Yuchiao Chang, PhD; Margaret C. Fang, MD, MPH; et al.
Ann Intern Med. 2009;151(5):297-305. doi:10.7326/0003-4819-151-5-200909010-00003
Reviews |  4 August 2009 FREE
Systematic Review: Comparative Effectiveness of Radiofrequency Catheter Ablation for Atrial Fibrillation
Teruhiko Terasawa, MD; Ethan M. Balk, MD, MPH; Mei Chung, MPH; et al.
Ann Intern Med. 2009;151(3):191-202. doi:10.7326/0003-4819-151-3-200908040-00131
Editorials |  17 March 2009 FREE
First Do No Harm … Reduction?
Marc N. Gourevitch, MD, MPH
Ann Intern Med. 2009;150(6):417-418. doi:10.7326/0003-4819-150-6-200903170-00111
Articles |  20 January 2009
Cost-Effectiveness of Using Pharmacogenetic Information in Warfarin Dosing for Patients With Nonvalvular Atrial Fibrillation
Mark H. Eckman, MD, MS; Jonathan Rosand, MD, MSc; Steven M. Greenberg, MD, PhD; et al.
Ann Intern Med. 2009;150(2):73-83. doi:10.7326/0003-4819-150-2-200901200-00005
Articles |  7 October 2008
Association of Electrocardiographic Morphology of Exercise-Induced Ventricular Arrhythmia with Mortality
Robert E. Eckart, DO; Michael E. Field, MD; Tomasz W. Hruczkowski, MD; et al.
Ann Intern Med. 2008;149(7):451-460. doi:10.7326/0003-4819-149-7-200810070-00005
Reviews |  21 August 2007
Systematic Review: Implantable Cardioverter Defibrillators for Adults with Left Ventricular Systolic Dysfunction
Justin A. Ezekowitz, MB, BCh, MSc; Brian H. Rowe, MD, MSc; Donna M. Dryden, PhD; et al.
Ann Intern Med. 2007;147(4):251-262. doi:10.7326/0003-4819-147-4-200708210-00007
Advertisement

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)